Oncology - Renal/Urologic News & Articles

1 Phase II, multicenter, uncontrolled trial of single-agent capecitabine in patients with non-clear cell metastatic renal cell carcinoma American Journal of Clinical Oncology, May 23, 2012    Clinical Article

2 Greater Percent-free Testosterone Is Associated With High-grade Prostate Cancer in Men Undergoing Prostate Biopsy Urology, May 23, 2012    Clinical Article

3 Cost-Effectiveness Analysis of Stereotactic Body Radiation Therapy Versus Intensity-Modulated Radiation Therapy: An Emerging Initial Radiation Treatment Option for Organ-Confined Prostate Cancer Journal of Oncology Practice, May 23, 2012    Clinical Article

4 Contrasted effects of the multitarget TKi vandetanib on docetaxel-sensitive and docetaxel-resistant prostate cancer cell lines Urologic Oncology: Seminars and Original Investigations, May 23, 2012    Clinical Article

5 The prostate cancer conundrum revisited Cancer, May 23, 2012    Clinical Article

6 Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma Cancer, May 23, 2012

7 A review of expression profiling of circulating microRNAs in men with prostate cancer BJU International, May 23, 2012

8 Resveratrol induces apoptosis associated with mitochondrial dysfunction in bladder carcinoma cells International Journal of Urology, May 23, 2012

9 Clinical outcome in patients receiving systemic therapy for metastatic sarcomatoid renal cell carcinoma: A retrospective analysis Urologic Oncology: Seminars and Original Investigations, May 23, 2012    Clinical Article

10 Simultaneous progression of oxidative stress, angiogenesis, and cell proliferation in prostate carcinoma Urologic Oncology: Seminars and Original Investigations, May 23, 2012

11 Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma Urologic Oncology: Seminars and Original Investigations, May 23, 2012    Clinical Article

12 Comparison of biochemical failure definitions for predicting local cancer recurrence following cryoablation of the prostate The Prostate, May 23, 2012

13 MicroRNAs as putative mediators of treatment response in prostate cancer Nature Reviews Urology, May 23, 2012    Clinical Article

14 Epithelioid Sarcoma of the Penis: A Case Report The Journal of Sexual Medicine, May 23, 2012

15 An Advanced but Traditional Technique of Transurethral Resection of the Prostate in Order not to Overlook Stage T1 Prostate Cancer Current Urology, May 23, 2012    Clinical Article

16 Metastasis to the Penis from Rectal Adenocarcinoma Anticancer Research, May 23, 2012

17 Complete Chemotherapeutic Regression of a Non-Metastatic Case of Primary Pure Small Cell Carcinoma of the Prostate Current Urology, May 23, 2012    Clinical Article

18 Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis International Journal of Cancer, May 22, 2012    Review Article

19 Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function European Journal of Cancer, May 22, 2012    Clinical Article

20 Interactions Between Normal Human Fibroblasts and Human Prostate Cancer Cells in a Co-culture System Anticancer Research, May 22, 2012

Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies Journal of Thoracic Disease, 08/05/2011

1 Abiraterone in Prostate Cancer Clinical Cancer Research, April 9, 2012

2 Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: Incidence, radiographic findings and correlation with clinical outcome European Journal of Cancer, April 11, 2012

3 Intermittent hormonal therapy in the treatment of metastatic prostate cancer: a randomized trial BJU International, April 20, 2012

4 Sipuleucel-T (Provenge) for castration-resistant prostate cancer BJU International, April 17, 2012

5 Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy Cancer, April 24, 2012

6 Novel combination markers for predicting progression of nonmuscle invasive bladder cancer International Journal of Cancer, April 23, 2012

7 Increase in cholesterol predicts survival advantage in renal cell carcinoma patients treated with temsirolimus Clinical Cancer Research, April 5, 2012

8 Microscopic and nuclear morphometric findings of chromophobe renal cell carcinoma, renal oncocytoma, and tumor with overlapping histology Annals of Diagnostic Pathology, April 13, 2012

9 Novel Molecular Targets for the Therapy of Castration-Resistant Prostate Cancer European Urology, April 23, 2012    Free full text

10 Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Establishment of Novel Preoperative Risk Stratification Model in Bladder Cancer Patients Treated with Radical Cystectomy Urology, April 5, 2012

11 Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study The Lancet Oncology - Online First, April 20, 2012

12 Systematic Review of Oncological Outcomes Following Surgical Management of Localised Renal Cancer European Urology, April 26, 2012    Free full text    Evidence Based Medicine

13 Assessment of the pathologic inclusion criteria from contemporary adjuvant clinical trials for predicting disease progression after nephrectomy for renal cell carcinoma Cancer, April 26, 2012

14 Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis Annals of Oncology, March 14, 2012    Evidence Based Medicine

15 Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer JAMA, April 19, 2012

16 Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade International Journal of Cancer, April 23, 2012

17 Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy The Prostate, April 18, 2012

18 New drugs for prostate cancer BJU International, April 19, 2012

19 Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer BJU International, April 16, 2012

20 Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinoma Journal of Clinical Oncology, March 26, 2012